Jarislowsky, Fraser LTD Abbott Laboratories Transaction History

Jarislowsky, Fraser LTD

$14.4 Billion
Q1 2025

A detailed history of Jarislowsky, Fraser LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Jarislowsky, Fraser LTD holds 2,169,717 shares of ABT stock, worth $290 Million. This represents 1.99% of its overall portfolio holdings.

Number of Shares

2,169,717

Previous 2,262,391 4.1%

Holding current value

$290 Million

Previous $256 Million 12.47%

% of portfolio

1.99%

Previous 1.66%

37 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$111.1 - $140.22 $10.3 Million - $13 Million	-92,674 Reduced 4.1%	2,169,717 $288 Million
Q4 2024 Feb 14, 2025	SELL	$111.93 - $119.39 $12.9 Million - $13.7 Million	-114,939 Reduced 4.83%	2,262,391 $256 Million
Q3 2024 Nov 13, 2024	BUY	$100.07 - $118.13 $17.3 Million - $20.4 Million	172,772 Added 7.84%	2,377,330 $271 Million
Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $12.6 Million - $14 Million	124,685 Added 5.99%	2,204,558 $229 Million
Q1 2024 Sep 30, 2024	SELL	$109.52 - $120.96 $4.66 Million - $5.14 Million	-42,532 Reduced 2.0%	2,079,873 $236 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $4.66 Million - $5.14 Million	-42,532 Reduced 2.0%	2,079,873 $236 Million
Q4 2023 Sep 30, 2024	SELL	$90.19 - $110.4 $7.41 Million - $9.07 Million	-82,153 Reduced 3.73%	2,122,405 $234 Million
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $5.27 Million - $6.46 Million	-58,487 Reduced 2.68%	2,122,405 $234 Million
Q3 2023 Sep 30, 2024	SELL	$95.53 - $114.62 $2.26 Million - $2.71 Million	-23,666 Reduced 1.07%	2,180,892 $211 Million
Q3 2023 Nov 06, 2023	SELL	$95.53 - $114.62 $1.65 Million - $1.98 Million	-17,300 Reduced 0.79%	2,180,892 $211 Million
Q2 2023 Sep 27, 2024	SELL	$100.78 - $112.29 $6.05 Million - $6.74 Million	-59,999 Reduced 2.66%	2,198,192 $240 Million
Q2 2023 Jul 19, 2023	SELL	$100.78 - $112.29 $6.05 Million - $6.74 Million	-59,999 Reduced 2.66%	2,198,192 $240 Million
Q1 2023 Sep 27, 2024	BUY	$96.86 - $114.01 $5.19 Million - $6.11 Million	53,633 Added 2.43%	2,258,191 $229 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $1.91 Million - $2.25 Million	-19,754 Reduced 0.87%	2,258,191 $229 Million
Q4 2022 Sep 27, 2024	BUY	$95.06 - $111.52 $6.98 Million - $8.18 Million	73,387 Added 3.33%	2,277,945 $250 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $2.24 Million - $2.63 Million	-23,580 Reduced 1.02%	2,277,945 $250 Million
Q3 2022 Nov 07, 2022	SELL	$96.76 - $112.03 $525,406 - $608,322	-5,430 Reduced 0.24%	2,301,525 $223 Million
Q2 2022 Jul 27, 2022	SELL	$102.07 - $123.37 $4.71 Million - $5.69 Million	-46,122 Reduced 1.96%	2,306,955 $251 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $11.6 Million - $14.2 Million	101,994 Added 4.53%	2,353,077 $279 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $2.39 Million - $2.93 Million	-20,723 Reduced 0.91%	2,251,083 $317 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $2.91 Million - $3.22 Million	-24,981 Reduced 1.09%	2,271,806 $268 Million
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $2.11 Million - $2.48 Million	19,907 Added 0.87%	2,296,787 $266 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $2.08 Million - $2.45 Million	-19,134 Reduced 0.83%	2,276,880 $273 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $912,135 - $993,966	8,687 Added 0.38%	2,296,014 $251 Million
Q3 2020 Nov 03, 2020	BUY	$91.64 - $111.29 $443,995 - $539,200	4,845 Added 0.21%	2,287,327 $249 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $2.61 Million - $3.35 Million	-34,137 Reduced 1.47%	2,282,482 $209 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $3.71 Million - $5.43 Million	-59,112 Reduced 2.49%	2,316,619 $183 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $2.48 Million - $2.76 Million	31,636 Added 1.35%	2,375,731 $206 Million
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $16.3 Million - $17.6 Million	198,730 Added 9.26%	2,344,095 $196 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $464,391 - $541,620	6,372 Added 0.3%	2,145,365 $180 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $7.25 Million - $8.77 Million	-109,509 Reduced 4.87%	2,138,993 $171 Million
Q4 2018 Feb 01, 2019	SELL	$65.56 - $74.27 $15.7 Million - $17.8 Million	-239,523 Reduced 9.63%	2,248,502 $163 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $85,985 - $103,731	1,414 Added 0.06%	2,488,025 $172 Million
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $5.98 Million - $6.6 Million	103,836 Added 4.36%	2,486,611 $152 Million
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $234,814 - $265,486	4,173 Added 0.18%	2,382,775 $0
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $583,018 - $624,181	-10,861 Reduced 0.45%	2,378,602 $0
Q3 2017 Nov 06, 2017	BUY	$48.06 - $53.64 $115 Million - $128 Million	2,389,463	2,389,463 $128 Million

Others Institutions Holding ABT

# of Institutions

3,541

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $234B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jarislowsky, Fraser LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jarislowsky, Fraser LTD with notifications on news.

Account

Jarislowsky, Fraser LTD Abbott Laboratories Transaction History